Here, we developed a GEM model specifically for EML4‐ALK lung cancer and found that XMU‐MP‐5 led to strong tumor regression resulting from ALK activity inhibition and tumor cell apoptosis. The gene discussed is ALK; the disease is lung carcinoma.